Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerold Schuler

Showing results (131-140 of 188) with videos related to

Pageof 19
Sort By:
International Journal of Cancer|February 3, 2005
Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patientsChristian Maczek, Thomas G Berger, Beatrice Schuler-Thurner, et al.
The Journal of Investigative Dermatology|April 9, 2005
Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISAVassiliki Bekou, Sybille Thoma-Uszynski, Olaf Wendler, et al.
Science Signaling|March 16, 2017
Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytesChristian Ostalecki, Jung-Hyun Lee, Jochen Dindorf, et al.
Inflammatory Bowel Diseases|July 15, 2017
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative ColitisCaroline J Voskens, Anika Fischer, Susanne Roessner, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2018
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patientsMichael Constantin Kirchberger, Selma Ugurel, Johanna Mangana, et al.
BMC Cancer|August 19, 2017
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanomaDennis C Harrer, Bianca Simon, Shin-Ichiro Fujii, et al.
AIDS (London, England)|August 2, 2008
Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNAChristian Hofmann, Thomas Harrer, Verena Kubesch, et al.
The World Allergy Organization Journal|October 18, 2021
Plasma-derived extracellular vesicles discriminate type-1 allergy subjects from non-allergic controlsNicola Wagner, Martin Eberhardt, Julio Vera, et al.
Cancer Research|May 14, 2009
The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cellsViolaine François, Sabrina Ottaviani, Nicolina Renkvist, et al.
The Journal of Investigative Dermatology|July 25, 2017
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Thomas Kurt Eigentler, Ulrike Keim, et al.
Pageof 19

Showing results (131-140 of 188) with videos related to

Sort By:
Pageof 19
International Journal of Cancer|February 3, 2005
Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patientsChristian Maczek, Thomas G Berger, Beatrice Schuler-Thurner, et al.
The Journal of Investigative Dermatology|April 9, 2005
Detection of laminin 5-specific auto-antibodies in mucous membrane and bullous pemphigoid sera by ELISAVassiliki Bekou, Sybille Thoma-Uszynski, Olaf Wendler, et al.
Science Signaling|March 16, 2017
Multiepitope tissue analysis reveals SPPL3-mediated ADAM10 activation as a key step in the transformation of melanocytesChristian Ostalecki, Jung-Hyun Lee, Jochen Dindorf, et al.
Inflammatory Bowel Diseases|July 15, 2017
Characterization and Expansion of Autologous GMP-ready Regulatory T Cells for TREG-based Cell Therapy in Patients with Ulcerative ColitisCaroline J Voskens, Anika Fischer, Susanne Roessner, et al.
European Journal of Cancer (Oxford, England : 1990)|May 30, 2018
MEK inhibition may increase survival of NRAS-mutated melanoma patients treated with checkpoint blockade: Results of a retrospective multicentre analysis of 364 patientsMichael Constantin Kirchberger, Selma Ugurel, Johanna Mangana, et al.
BMC Cancer|August 19, 2017
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanomaDennis C Harrer, Bianca Simon, Shin-Ichiro Fujii, et al.
AIDS (London, England)|August 2, 2008
Generation of HIV-1-specific T cells by electroporation of T-cell receptor RNAChristian Hofmann, Thomas Harrer, Verena Kubesch, et al.
The World Allergy Organization Journal|October 18, 2021
Plasma-derived extracellular vesicles discriminate type-1 allergy subjects from non-allergic controlsNicola Wagner, Martin Eberhardt, Julio Vera, et al.
Cancer Research|May 14, 2009
The CD4(+) T-cell response of melanoma patients to a MAGE-A3 peptide vaccine involves potential regulatory T cellsViolaine François, Sabrina Ottaviani, Nicolina Renkvist, et al.
The Journal of Investigative Dermatology|July 25, 2017
Serial or Parallel Metastasis of Cutaneous Melanoma? A Study of the German Central Malignant Melanoma RegistryMaximilian Gassenmaier, Thomas Kurt Eigentler, Ulrike Keim, et al.
Pageof 19